Y., Noh, S
[Ref] Renal Common (1% to 10%): Kidney failure (chronic hemodialysis patients) [Ref] Endocrine Common (1% to 10%): Parathyroid disorder [Ref] Respiratory Very common (10% or more): Pharyngitis (27%), cough increase (18%), dyspnea (11%), rhinitis (11%) Common (1% to 10%): Bronchitis, sinusitis [Ref] Dermatologic Common (1% to 10%): Pruritus, rash [Ref] Ocular Common (1% to 10%): Amblyopia, eye disorder [Ref] Genitourinary Common (1% to 10%): Urinary tract infection [Ref] Cardiovascular Very common (10% or more): Hypertension (21%), hypotension (19%) Common (1% to 10%): Atrial fibrillation, arrhythmia, cardiovascular disorder, electrocardiogram abnormal, palpitations, tachycardia, vascular disorder [Ref] Hypersensitivity Common (1% to 10%): Allergic reaction [Ref] Psychiatric Common (1% to 10%): Depression, anxiety, drug dependence, insomnia [Ref] Immunologic Very common (10% or more): Infection (24%) [Ref] References 1
10.1007/s40279-019-01181-y 53 TsaiW
Como explica Andreea Ciudin Mihai , coordinadora de la Unidad de Tratamiento de la Obesidad del Servicio de Endocrinologa y Nutricin del Hospital Universitario Vall d' Hebron, e l GLP-1 endgeno se sintetiza en las clulas L del intestino terminal, tras una ingesta , y su vida media es de unos minutos, suficiente para estimular la liberacin de insulina dependiente de glucosa, y activar sus receptores en el resto de rganos para los efectos postprandiales
